Dr Tifelle Reisinger is a medicinal chemist with 9 years drug discovery experience in the pharmaceutical and CRO industries in France, UK and Australia.
Tifelle has worked on programs from hit identification through to candidate nomination in the fields of oncology, cardiovascular diseases and neurosciences.
Tifelle relocated from the UK to Melbourne in 2017 as Head of Business Development, Asia Pacific for Domainex, a drug discovery service company. With a strong client-focus and business acumen, Tifelle generated and managed a portfolio of clients with ownership of the full sales cycle, with biotech companies, VCs and leading academic research institutes across Australia. She has built successful relationships based on understanding client needs, creating bespoke solutions and delivering value to international clients and utilising her business development, project and contract management skills.
Tifelle completed her Ph.D. in organic chemistry at The University of Paris and the Institute of Chemistry of Natural Substances (ICSN) in France and undertook further post-doctoral studies at the University of Cambridge in UK.